BMC Clinical Pharmacology

unofficial impact factor 1.36

Open Access Research article

Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple intravenous administrations: an open-label randomised controlled trial

Fritz Sörgel*, Ursula Thyroff-Friesinger, Andrea Vetter, Bernhard Vens-Cappell and Martina Kinzig

BMC Clinical Pharmacology 2009, 9:10 doi:10.1186/1472-6904-9-10

No comments have yet been made on this article.

Post a comment